The purpose of our study was to collect a series of lung carcinomas with BRAF mutations and examine their clinicopathological features, with special emphasis on the following: (1) distinction between V600E and non-V600E mutations, (2) distinction between BRAF mutations alone and BRAF with co-mutations. Here, BRAF is linked to lung carcinoma.